Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
45
BLCO.TO Quote, Financials, Valuation and Earnings
Last price:
$22.20
Seasonality move
:
5.47%
Day range:
$22.06 - $23.64
52-week range:
$14.56 - $26.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.13x
P/B ratio:
0.88x
Volume:
16.2K
Avg. volume:
2.1K
1-year change:
-14.42%
Market cap:
$7.9B
Revenue:
$6.6B
EPS (TTM):
-$1.23
Analysts' Opinion
-
Consensus RatingBausch + Lomb Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $24.48, Bausch + Lomb Corp. has an estimated upside of 10.26% from its current price of $22.20.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $24.48 representing 100% downside risk from its current price of $22.20.
Fair Value
-
According to the consensus of 12 analysts, Bausch + Lomb Corp. has 10.26% upside to fair value with a price target of $24.48 per share.
BLCO.TO vs. S&P 500
-
Over the past 5 trading days, Bausch + Lomb Corp. has underperformed the S&P 500 by -4.9% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Bausch + Lomb Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bausch + Lomb Corp. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Bausch + Lomb Corp. reported revenues of $1.8B.
Earnings Growth
-
Bausch + Lomb Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Bausch + Lomb Corp. reported earnings per share of -$0.11.
Enterprise value:
14.4B
EV / Invested capital:
--
Price / LTM sales:
1.13x
EV / EBIT:
73.97x
EV / Revenue:
2.07x
PEG ratio (5yr expected):
-1.10x
EV / Free cash flow:
-52.90x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
18.14x
Gross Profit (TTM):
$3.8B
Return On Assets:
-2.21%
Net Income Margin (TTM):
-6.04%
Return On Equity:
-4.61%
Return On Invested Capital:
-2.64%
Operating Margin:
6.25%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $5.4B | $6.4B | $7B | $1.6B | $1.8B | |
| Gross Profit | $2.9B | $3.5B | $3.8B | $900.2M | $968.3M | |
| Operating Income | $257.3M | $257.6M | $194.5M | $88.7M | $110.2M | |
| EBITDA | $741.5M | $864.5M | $793M | $238.7M | $260.3M | |
| Diluted EPS | -$0.80 | -$1.42 | -$1.23 | $0.02 | -$0.11 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2B | $2.6B | $3.3B | $3.8B | $4B | |
| Total Assets | $14.1B | $14.7B | $17.7B | $18.3B | $19.2B | |
| Current Liabilities | $1.4B | $1.6B | $1.9B | $2.4B | $2.6B | |
| Total Liabilities | $2.1B | $5.4B | $8.4B | $9.3B | $10.2B | |
| Total Equity | $12B | $9.3B | $9.3B | $9B | $9B | |
| Total Debt | -- | $3.3B | $6B | $6.3B | $6.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $157.3M | $305.6M | $238.1M | $209.5M | $191.5M | |
| Cash From Investing | -$2.8B | -$454.4M | -$629.3M | -$131M | -$83.1M | |
| Cash From Financing | $2.7B | $123.6M | $352.8M | -$26.9M | -$18.1M | |
| Free Cash Flow | -$87.1M | -$75.7M | -$272M | $127.4M | $90.1M | |
BLCO.TO
Sector
Market Cap
$7.9B
$27.9M
Price % of 52-Week High
82.62%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
-1.48%
-1.49%
1-Year Price Total Return
-14.42%
-16.66%
Beta (5-Year)
--
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$23.24
200-day SMA
Buy
Level
$19.63
Bollinger Bands (100)
Buy
Level
19.9 - 22.48
Chaikin Money Flow
Sell
Level
-211.3K
20-day SMA
Sell
Level
$23.04
Relative Strength Index (RSI14)
Sell
Level
45.47
ADX Line
Buy
Level
26.71
Williams %R
Buy
Level
-94.7566
50-day SMA
Buy
Level
$22.17
MACD (12, 26)
Buy
Level
0.29
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Sell
Level
-176.1K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9722)
Buy
CA Score
(Annual)
Level (-0.2836)
Buy
Beneish M-Score
(Annual)
Level (-2.4166)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.6237)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.
Stock Forecast FAQ
In the current month, BLCO.TO has received 4 Buy ratings 8 Hold ratings, and 0 Sell ratings. The BLCO.TO average analyst price target in the past 3 months is $24.48.
-
Where Will Bausch + Lomb Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bausch + Lomb Corp. share price will rise to $24.48 per share over the next 12 months.
-
What Do Analysts Say About Bausch + Lomb Corp.?
Analysts are divided on their view about Bausch + Lomb Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bausch + Lomb Corp. is a Sell and believe this share price will drop from its current level to $24.48.
-
What Is Bausch + Lomb Corp.'s Price Target?
The price target for Bausch + Lomb Corp. over the next 1-year time period is forecast to be $24.48 according to 12 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is BLCO.TO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bausch + Lomb Corp. is a Hold. 8 of 12 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BLCO.TO?
You can purchase shares of Bausch + Lomb Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bausch + Lomb Corp. shares.
-
What Is The Bausch + Lomb Corp. Share Price Today?
Bausch + Lomb Corp. was last trading at $22.20 per share. This represents the most recent stock quote for Bausch + Lomb Corp.. Yesterday, Bausch + Lomb Corp. closed at $22.20 per share.
-
How To Buy Bausch + Lomb Corp. Stock Online?
In order to purchase Bausch + Lomb Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get BLCO.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BLCO.TO
Sector
P/E ratio
--
23.85x
PEG ratio
-1.10x
-0.01x
P/B ratio
0.88x
1.81x
Price / LTM sales
1.13x
1.58x
Growth Metrics
BLCO.TO
Sector
Revenue growth
8.16%
4.62%
Earnings growth
-807.14%
10.5%
Revenue (5-year growth)
5.54%
6.5%
Earnings forecast
$0.10
-$0.21
Profitability
BLCO.TO
Sector
Profitability FY 2024
$3.6B
$3.6M
Return on invested capital
-2.64%
-31.87%
Return on assets
-2.21%
-28.18%
Return on equity
-4.61%
-37.63%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
18
Estimated Next Earnings Date
Jan
28
Balance Sheet
BLCO.TO
Sector
Total cash
$461.9M
$26.4M
Short term investments
--
$25.7M
Total assets
$19.4B
$76.9M
Long term debt
$6.9B
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
